Wilko Weichert
Wilko Weichert
Institute of Pathology, Technical University Munich (TUM)
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer
C Denkert, S Loibl, A Noske, M Roller, BM Müller, M Komor, J Budczies, ...
Journal of clinical oncology 28 (1), 105-113, 2010
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
I Baccelli, A Schneeweiss, S Riethdorf, A Stenzinger, A Schillert, V Vogel, ...
Nature biotechnology 31 (6), 539-544, 2013
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
A Afshar-Oromieh, E Avtzi, FL Giesel, T Holland-Letz, HG Linhart, M Eder, ...
European journal of nuclear medicine and molecular imaging 42, 197-209, 2015
The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma …
A Warth, T Muley, M Meister, A Stenzinger, M Thomas, P Schirmacher, ...
Journal of clinical oncology 30 (13), 1438-1446, 2012
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
W Weichert, A Röske, V Gekeler, T Beckers, C Stephan, K Jung, ...
British journal of cancer 98 (3), 604-610, 2008
Fungi and inflammatory bowel diseases: alterations of composition and diversity
SJ Ott, T Kühbacher, M Musfeldt, P Rosenstiel, S Hellmig, A Rehman, ...
Scandinavian journal of gastroenterology 43 (7), 831-841, 2008
HDAC expression and clinical prognosis in human malignancies
W Weichert
Cancer letters 280 (2), 168-176, 2009
Mass spectrometry–based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors
C Denkert, J Budczies, T Kind, W Weichert, P Tablack, J Sehouli, ...
Cancer research 66 (22), 10795-10804, 2006
Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo
W Weichert, A Röske, S Niesporek, A Noske, AC Buckendahl, M Dietel, ...
Clinical Cancer Research 14 (6), 1669-1677, 2008
Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis
W Weichert, A Röske, V Gekeler, T Beckers, MPA Ebert, M Pross, M Dietel, ...
The lancet oncology 9 (2), 139-148, 2008
Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas
AH Scheel, M Dietel, LC Heukamp, K Jöhrens, T Kirchner, S Reu, ...
Modern Pathology 29 (10), 1165-1172, 2016
Targeted α-therapy of metastatic castration-resistant prostate cancer with 225Ac-PSMA-617: dosimetry estimate and empiric dose finding
C Kratochwil, F Bruchertseifer, H Rathke, M Bronzel, C Apostolidis, ...
Journal of Nuclear Medicine 58 (10), 1624-1631, 2017
Metabolite profiling of human colon carcinoma–deregulation of TCA cycle and amino acid turnover
C Denkert, J Budczies, W Weichert, G Wohlgemuth, M Scholz, T Kind, ...
Molecular cancer 7, 1-15, 2008
Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking
J Weischenfeldt, T Dubash, AP Drainas, BR Mardin, Y Chen, AM Stütz, ...
Nature genetics 49 (1), 65-74, 2017
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes
S Mueller, T Engleitner, R Maresch, M Zukowska, S Lange, ...
Nature 554 (7690), 62-68, 2018
ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival
W Weichert, T Knösel, J Bellach, M Dietel, G Kristiansen
Journal of clinical pathology 57 (11), 1160-1164, 2004
Distinct types of tumor-initiating cells form human colon cancer tumors and metastases
SM Dieter, CR Ball, CM Hoffmann, A Nowrouzi, F Herbst, O Zavidij, ...
Cell stem cell 9 (4), 357-365, 2011
Elevated expression of cyclooxygenase‐2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma
C Denkert, KJ Winzer, BM Müller, W Weichert, S Pest, M Köbel, ...
Cancer 97 (12), 2978-2987, 2003
CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy
CE Engeland, C Grossardt, R Veinalde, S Bossow, D Lutz, JK Kaufmann, ...
Molecular Therapy 22 (11), 1949-1959, 2014
Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer
A Noske, W Weichert, S Niesporek, A Röske, AC Buckendahl, I Koch, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20